CJCADR

Scanning ultrasound is emerging as one of the most promising tools in the fight against Alzheimer’s disease. At QBI, researchers are advancing the science behind this technology, while industry partners are helping move discoveries from the lab into the clinic.

A new device combining ultrasound and advanced imaging to provide crucial information for the safe delivery of drugs into the brain has been developed by QBI researchers.

A new review explores how exercise can reduce the risk of dementia and promote healthy brain ageing, suggesting we need to re-think global exercise guidelines. 

In Brain Awareness Week 2025, QBI hosted an event to bring the latest research and insight about living well with dementia to the community.

QBI researchers have discovered that nearly 70 per cent of suspected frontotemporal dementia patients ultimately did not have the disease in a study aimed at identifying factors that contribute to misdiagnosis of the disorder.

QBI researchers have discovered a molecule that protects brain cells from oxidative stress and damage, opening new avenues for possible treatments for brain diseases.

University of Queensland researchers have received two $3 million grants from the National Health and Medical Research Council (NHMRC) to accelerate knowledge and treatment of Alzheimer’s disease, and to improve gynaecological cancer treatment.

QBI researchers have generated a promising Tau antibody as a potential immunotherapy treatment aimed at targeting harmful Tau tangles, which cause various proteins in the brain to become dysregulated in Alzheimer's disease.

Emeritus Professor Perry Bartlett and Dr Daniel Blackmore from UQ’s Queensland Brain Institute led a longitudinal study to find that high-intensity interval exercise improves brain function in older adults for up to 5 years.

QBI researchers have discovered that targeting amyloid plaque is not essential to improve cognition with ultrasound treatment in patients with neurodegenerative disorders.